Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

When is it Appropriate to Stop? Applied Field Research to Develop an M&E Strategy to

NCT04124250 is registered in ClinicalTrials.gov with University Hospitals Cleveland Medical Center as lead sponsor.

NCT NCT04124250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04124250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
When is it Appropriate to Stop? Applied Field Research to Develop an M&E Strategy to
Lead sponsor
University Hospitals Cleveland Medical Center
Phase
Observational
Overall status
Completed
Start date
September 17, 2019
Completion date
January 1, 2024
Enrollment
12,930 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acceptability of mass drug administration for lymphatic filariasis, lymphatic filariasis elimination by mass drug administration, monitoring and evaluation of mass drug administration for lymphatic filariasis